News
Objectives To investigate the effects of overwork on brain structure to better understand its impact on workers’ cognitive ...
Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...
A recent survey from The Queen’s Reading Room, the charity and book club of Queen Camilla, and other surveys, have found that ...
This rumor circulated in May 2025 amid news of Qatar offering the U.S. Department of Defense a $400 million luxury Boeing 747 ...
As the UPSC Prelims 2025 approaches, aspirants are racing against time to refine their strategies. With only weeks left, ...
Q1 2025 Earnings Call Transcript May 13, 2025 Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...
Have you heard of brainspotting? It's been around since 2003 when it was invented out of whole cloth (not "discovered") by ...
15h
GlobalData on MSNCIMA updates CGMA Professional Qualification syllabusThe new syllabus is aimed at enhancing core competencies such as finance business partnering, analytical thinking, and ...
Oats (Avena sativa) are a widely consumed cereal grain known for their exceptional nutritional profile and diverse health ...
This article presents a comprehensive review of Pilly Labs Mushroom Extract Complex, the functional mushroom gummy formula ...
David Hogg’s disdain for his own party found him slamming Democrats for the 10-figure cost in attempting to get Americans ...
NEW YORK and BERLIN, May 14, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results